Share This Page
Drug Price Trends for ACULAR
✉ Email this page to a colleague
Average Pharmacy Cost for ACULAR
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ACULAR 0.5% EYE DROPS | 00023-2181-05 | 53.09520 | ML | 2024-11-20 |
| ACULAR 0.5% EYE DROPS | 00023-2181-05 | 53.09520 | ML | 2024-10-23 |
| ACULAR 0.5% EYE DROPS | 00023-2181-05 | 52.90800 | ML | 2024-09-18 |
| ACULAR 0.5% EYE DROPS | 00023-2181-05 | 53.08733 | ML | 2024-08-21 |
| ACULAR 0.5% EYE DROPS | 00023-2181-05 | 53.01886 | ML | 2024-07-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Acular
Overview of Acular
Acular, also known as ketorolac ophthalmic, is a member of the ophthalmic anti-inflammatory agents drug class. It is commonly used to treat conditions such as corneal refractive surgery, postoperative ocular inflammation, and seasonal allergic conjunctivitis[5].
Market Context: Ophthalmic Drugs
The ophthalmic drugs market, within which Acular operates, is experiencing significant growth driven by several key factors.
Global Ophthalmic Drugs Market Growth
The global ophthalmic drugs market was valued at $32.9 billion in 2021 and is projected to reach $62.55 billion by 2030, growing at a CAGR of 7.4% during the forecast period[3].
Regional Market Dynamics
- North America: This region holds the largest market share in the global ophthalmic drugs market. The U.S. ophthalmic drugs market alone was estimated at $15.53 billion in 2023 and is anticipated to grow at a CAGR of 7.4% from 2024 to 2030[4].
- Asia-Pacific: This region is expected to grow at a significant rate due to a large patient pool, high illness prevalence, and the rise of local businesses. The Asia-Pacific region has the largest patient population but the lowest treatment rate, which is expected to drive market growth[3].
Ocular Drug Delivery Market
The ocular drug delivery market, which includes drugs like Acular, is also seeing substantial growth.
Market Size and Growth
The global ocular drug delivery market was valued at $67.7 billion in 2022 and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032. This growth is driven by advancements in ocular drug delivery technology, an increase in the aging population, and rising awareness about various eye disorders[1].
Key Drivers
- Aging Population: The increase in the aging population is a significant driver, as this demographic is more susceptible to conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy[1].
- Technological Advancements: Improvements in ocular drug delivery technologies, such as implants, ointments, eye drops, injections, and contact lenses, are optimizing the therapeutic effects of medications while minimizing systemic side effects[1].
Price Analysis of Acular
Current Pricing
The cost for Acular 0.5% ophthalmic solution is around $300 for a supply of 5 milliliters, depending on the pharmacy. However, generic versions of ketorolac ophthalmic are available at significantly lower prices, starting from $38.06 for 5 milliliters[5].
Price Projections
Given the overall growth in the ophthalmic drugs market and the specific trends in the ocular drug delivery market, here are some insights into potential price projections:
- Generic Competition: The availability of generic versions of Acular is likely to keep prices competitive. As more generics enter the market, prices may stabilize or decrease slightly.
- Market Demand: Increasing demand due to the growing prevalence of eye disorders and an aging population could lead to stable or slightly increasing prices, especially for branded products.
- Technological Advancements: Improvements in drug delivery technologies might lead to new formulations or delivery methods, which could impact pricing. However, these advancements are more likely to enhance the value proposition rather than significantly alter the price point.
Regional Pricing Variations
Prices can vary significantly by region due to factors such as healthcare policies, reimbursement rates, and local market dynamics.
- North America: In the U.S., prices are influenced by insurance plans, copay cards, and patient assistance programs. Generic versions are likely to remain affordable, while branded products may see stable pricing due to market demand[5].
- Asia-Pacific: In this region, prices may be lower due to local market conditions and the presence of generic manufacturers. However, the growing middle class and increasing healthcare expenditure could support higher prices for premium products[3].
Key Takeaways
- Market Growth: The ophthalmic drugs market, including ocular drug delivery, is experiencing robust growth driven by an aging population and technological advancements.
- Price Stability: Prices for Acular and its generic versions are likely to remain competitive due to generic competition and market demand.
- Regional Variations: Pricing will vary by region, influenced by local healthcare policies and market dynamics.
FAQs
What is the current market size of the global ocular drug delivery market?
The global ocular drug delivery market was valued at $67.7 billion in 2022[1].
What is the projected growth rate of the global ocular drug delivery market?
The market is projected to grow at a CAGR of 5.5% from 2023 to 2032[1].
What are the key drivers of the ocular drug delivery market?
Key drivers include advancements in ocular drug delivery technology, an increase in the aging population, and rising awareness about various eye disorders[1].
How does the pricing of Acular compare to its generic version?
The branded version of Acular costs around $300 for 5 milliliters, while the generic version starts at $38.06 for the same quantity[5].
Which region is expected to grow the fastest in the ophthalmic drugs market?
The Asia-Pacific region is expected to grow at the fastest rate due to a large patient pool and increasing healthcare expenditure[3].
Sources
- Allied Market Research - Ocular Drug Delivery Market Statistics, Growth Forecast- 2032
- IQVIA - Quarterly Pharmaceutical Market Outlook - November 2023
- Straits Research - Ophthalmic Drugs Market Size to Grow at a CAGR of 7.4% by 2030
- Grand View Research - U.S. Ophthalmic Drugs Market Size | Industry Report, 2030
- Drugs.com - Acular Prices, Coupons, Copay Cards & Patient Assistance
More… ↓
